Amyloidosis

Research

Many patients at Seattle Cancer Care Alliance (SCCA) receive promising therapies by taking part in clinical trials. These research studies are done by physician-scientists from SCCA, Fred Hutchinson Cancer Research Center and UW Medicine. They test new treatments or new ways to use current treatments.

Every advance in cancer treatment in recent years has come out of clinical trials. We offer more active clinical trials than anywhere else, which means more treatment options for patients like you.

Clinical trials

For some people, taking part in a clinical study may be the best treatment choice. Access to clinical studies by researchers at SCCA and our founding organizations Fred Hutch and UW Medicine is one reason many patients come to SCCA. 

Important areas of research include: 

  • New combinations of chemotherapy medicines and steroids
  • Stem cell transplants for amyloidosis
  • Medicines that stimulate the removal of amyloid from the body 
  • For familial amyloidosis, RNA interference therapy that can turn off the production of the abnormal TTR protein by the liver
  • Palliative care to improve your quality of life and comfort 

Our research interests also include studies to better understand the basics of the disease and its risk factors and to help more patients receive a diagnosis earlier.